Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This is a phase I/IIa study to evaluate the safety, tolerability and preliminary efficacy of
IAH0968 in patients with HER2-positive advanced solid tumors who have failed standard
treatment.